You are here

Pharma CEOs

A struggling Sanofi is preparing to hire Novartis senior pharma exec Paul Hudson as new CEO, replacing Brandicourt -- report

Endpoints

Thu, 06/6/19 - 11:08 pm

Olivier Brandicourt

From BIO meeting, Merck CEO Ken Frazier defends capitalism, drug industry

Biopharma Dive

Wed, 06/5/19 - 07:29 pm

Follow the money: How biopharma CEOs and workers got paid in 2018

Biopharma Dive

Thu, 05/30/19 - 05:41 pm

Novartis chief Vas Narasimhan wants you to know about the '25-plus’ blockbusters he has in the pipeline

Endpoints

Thu, 05/23/19 - 12:46 pm

Novartis CEO plans gene therapy price 'far lower' than $4 million to $5 million range

Yahoo/Reuters

Thu, 05/23/19 - 09:48 am

Commentary: Novartis CEO: Gene therapy offers hope of cures in one treatment, but US needs new pricing and payment model

CNBC

Fri, 05/17/19 - 07:21 pm

Merck CEO, Ken Frazier's Unusual Priority -- Science

Forbes

Wed, 05/15/19 - 10:33 am

Allergan CEO Saunders hangs on to chairman's title, winning shareholder support — but not by a big enough margin to squelch critics

Endpoints

Wed, 05/1/19 - 12:23 pm

Novartis Poaches GSK Veteran as New Sandoz CEO

BioSpace

Wed, 04/24/19 - 11:48 am

Seattle Genetics CEO Clay Siegall's comp package soars to $18.1M, rivaling Big Pharma chiefs

Endpoints

Mon, 04/22/19 - 11:09 am

Seattle Genetics

Struggling Insys swaps CEOs as Subsys marketing crackdown continues

Fierce Pharma

Tue, 04/16/19 - 07:58 pm

INSYS Therapeutics

Revenue plunges, stock takes a drubbing, but Teva CEO Kåre Schultz still grabs $32.5M in chart-topping compensation

Endpoints

Tue, 04/16/19 - 07:51 pm

Teva Pharmaceutical

Biopharma CEOs Explain Problems With Biosimilars to Congress

RAPS.org

Sat, 04/13/19 - 12:15 pm

Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene

CNBC

Sat, 04/13/19 - 12:03 pm

Bristol-Myers Squibb

Giovanni Caforio

It’s a seller’s world in biotech M&A, and Novartis CEO Vas Narasimhan has his check book out and pen ready

Endpoints

Tue, 04/9/19 - 08:31 am

Novartis CEO's $50 Billion of Deals Was Just the First Act

Yahoo/Bloomberg

Thu, 04/4/19 - 12:01 pm

AbbVie shareholder joins the growing ranks of critics, calling for an independent chairman

Endpoints

Wed, 04/3/19 - 12:50 pm

Richard Gonzalez

Alexion chief registers $16.5M in pay after a solid year, with a relatively low 74-to-1 ratio compared to a well paid staff

Endpoints

Tue, 03/26/19 - 10:15 am

After landing a historic FDA OK, Alnylam chief John Maraganore scores a big raise

Endpoints

Fri, 03/22/19 - 10:11 pm

John Maraganore

Exclusive: Sanofi says working on CEO succession plan

Yahoo/Reuters

Mon, 03/18/19 - 05:04 pm

Olivier Brandicourt

Pages